Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5110523013 | (S)-metoprolol succinate (substance) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 5110524019 | (S)-metoprolol succinate | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| (S)-metoprolol succinate (substance) | Is a | Beta-1 adrenergic receptor antagonist | true | Inferred relationship | Some | ||
| (S)-metoprolol succinate (substance) | Is a | Propanolamine (substance) | true | Inferred relationship | Some | ||
| (S)-metoprolol succinate (substance) | Has disposition (attribute) | Beta-1 adrenergic receptor antagonist (disposition) | true | Inferred relationship | Some | ||
| (S)-metoprolol succinate (substance) | Is modification of (attribute) | Metoprolol (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has precise active ingredient | True | (S)-metoprolol succinate (substance) | Inferred relationship | Some | 2 |
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has precise active ingredient | True | (S)-metoprolol succinate (substance) | Inferred relationship | Some | 2 |
This concept is not in any reference sets
FHIR